MTVA MetaVia Inc.
Company Analysis
Latest News
🔴 MetaVia is trading 5% down today — no clear catalyst identified
MetaVia is trading 5.14% down now at $1.66, with no credible company-specific catalyst identified. - No credible September 11, 2026 company-specific...
MetaVia's Fat-Targeting Drug Data Lifts a $10 Million Micro-Cap — But Can Preclinical Science Bridge the Gap to a Crowded Obesity Market?
Shares of MetaVia (MTVA) jumped 7.6% to $1.83 on September 9 after the company released preclinical findings showing its lead obesity drug concentrates most...
🟢 MetaVia is trading 7.65% up today after DA-1726 showed highest exposure in adipose tissue
MetaVia is trading 7.65% up now at $1.83 after preclinical results showed DA-1726 was broadly distributed, with the highest tissue exposure in adipose...
🔴 MetaVia is trading 6.18% down today with no clear catalyst identified
MetaVia is trading 6.18% down at $1.59, reversing its September 8 close of $1.70, with no clear catalyst identified. - No company-specific announcement,...
🟢 MetaVia is trading 5.46% up in pre-market with no clear catalyst identified
MetaVia is trading 5.46% up at $1.79 in pre-market, with no clear company-specific catalyst identified for September 9, 2026. - The latest company update was...
🟢 MetaVia is trading 5% up in pre-market; catalyst unclear
MetaVia is trading 5.39% up at $1.84 in pre-market, based on the provided data, while the catalyst remains unclear. - No fresh company-specific announcement...
🟢 MetaVia is trading 5.7% up in after-hours trading with no confirmed company-specific catalyst
MetaVia is trading at $1.85, up 5.7% after-hours after closing at $1.75 on September 4, 2026, with no confirmed company-specific catalyst identified. - Its...
🔴 MetaVia is trading 7.61% down today — no clear company-specific announcement identified
MetaVia is trading 7.61% down at $1.70, with no clear company-specific announcement identified for September 4, 2026. - MetaVia’s investor-relations page...
🟢 MetaVia is trading 5.5% up today with no clear company-specific catalyst
MetaVia is trading 5.5% up at $1.92 after no clear company-specific catalyst emerged for September 03, 2026, with the move appearing aligned with broader risk...
🔴 MetaVia is trading 7.68% down in after-hours trading with no clear company-specific catalyst identified
MetaVia is trading 7.68% down at $1.68 after no clear company-specific catalyst was identified for September 2, 2026. - The investor-relations page lists...
🟢 MetaVia is trading 5.8% up today with no clear catalyst
MetaVia is trading 5.8% up now at $1.82, with no clear catalyst identified. - No company-specific announcement, filing, analyst action, or other clear...
🔴 MetaVia is trading 5% down in pre-market; no clear company-specific catalyst identified
MetaVia is trading at $1.63, down 5.23%, with no clear company-specific catalyst identified for September 1, 2026. - Investor relations lists August 6 as the...
🟢 MetaVia is trading 6.32% up in pre-market with no clear catalyst identified
MetaVia is trading 6.32% up at $1.76, with no clear company-specific announcement or overnight catalyst identified for August 28, 2026. - Its...
🔴 MetaVia is trading 5.25% down in pre-market with no company-specific catalyst identified
MetaVia is trading 5.25% down at $1.59 after no new company-specific announcement was identified for August 27, 2026. - Its investor-relations page lists...
🟢 MetaVia is trading 11.16% up today with no clear catalyst identified
MetaVia is trading 11.16% up at $1.70, with no clearly reported catalyst identified for August 25, 2026. - The latest major corporate update was the August 6,...
🟢 MetaVia is trading 6% up today
MetaVia is trading 5.97% higher at $1.62, extending its August 24 close of $1.53; no new company-specific announcement or clearly reported catalyst was...
🟢 MetaVia is trading 6.16% up in pre-market; reason unconfirmed
MetaVia is trading at $1.55 (+6.16%), with no clear catalyst identified. - No clear company-specific announcement or overnight catalyst was identified for...
🟢 MetaVia is trading 5.56% up in pre-market
MetaVia is trading at $1.52 (+5.56%) in pre-market, with no clear company-specific catalyst identified. - No clear company-specific catalyst was identified...
🟢 MetaVia is trading 5% up today as July CPI reduced rate-hike expectations
MetaVia is trading 5.01% up now at $1.49, moving higher alongside a broader risk-on session after July CPI showed inflation at 3.4% year over year and reduced...
MetaVia Inc. Q2 2026 Earnings Preview: What Analysts Expect on August 06, 2026
MetaVia is expected to report a Q2 2026 loss of $0.85 per share on zero revenue, while the current stock price of $1.48 remains significantly below the average...